Ray Therapeutics
USEntry
2021
Hold
5yr
Status
Active
Who owns Ray Therapeutics?
Ray Therapeutics is an American Biotech company, currently owned by Novo Holdings since 2023 and 4Bio Partners.
Hand-verified · updated 2026-07-08
Open JSON · CC-BY
Most recent investor
4Bio Partners4BIO Ventures III · 2022 · Life Sciences VC
2 ownership periods · full history below
Key facts
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2021 · present
4Bio PartnersActive
2021 · present(5yr) · 4BIO Ventures III · 2022 · Life Sciences VC
Novo HoldingsActive
2023 · present(3yr) · Novo Holdings Venture Investments · 1999 · VC
More from 4BIO Ventures III
Other portfolio companies in the same fund.
Italy
UK
Switzerland
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Ray Therapeutics?
Ray Therapeutics is currently owned by Novo Holdings and 4Bio Partners, through 4BIO Ventures III, since 2023.
When did Novo Holdings and 1 other acquire Ray Therapeutics?
Novo Holdings and 1 other acquired Ray Therapeutics in 2023.
Who has owned Ray Therapeutics over time?
Ray Therapeutics has been through 2 private-equity ownership periods: 4Bio Partners · via 4BIO Ventures III · since 2021; Novo Holdings · via Novo Holdings Venture Investments · since 2023.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue